SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-226618
Filing Date
2019-08-22
Accepted
2019-08-22 11:50:03
Documents
5
Period of Report
2019-09-26
Effectiveness Date
2019-08-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d696834ddef14a.htm DEF 14A 396732
2 GRAPHIC g696834g01u04.jpg GRAPHIC 24581
3 GRAPHIC g696834g72w52.jpg GRAPHIC 36467
4 GRAPHIC g696834page016.jpg GRAPHIC 237694
5 GRAPHIC g696834page017.jpg GRAPHIC 112513
  Complete submission text file 0001193125-19-226618.txt   964673
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32587 | Film No.: 191044840
SIC: 2834 Pharmaceutical Preparations